CLINICAL TRIAL / NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
- Interventional
- Recruiting
- NCT05710380
Contact Information
Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this research will last about 12 months. There is a one-time MRI and 1-2 biopsies and then the investigator would like to follow the participant's progress.